2m 2m 2m 2m 2m 2m 2m
TURN THERAPEUTIC (TTRX)
NASDAQ
$5.71-$0.28 (-4.67%)
Price as of Jun 23, 2026 7:52 PM EDT- $171.9MMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
TURN THERAPEUTIC (TTRX)
$5.71-$0.28 (-4.67%)
TTRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.99 | ||
Change | +$0.22 (+3.81%) | ||
Open | $5.71 | ||
High | $5.99 | ||
Low | $5.56 | ||
Previous Close | $5.77 | ||
Volume | 10,098 | ||
30-Day Average Volume | 59,788 | ||
1-Week Change | -2.76% | ||
1-Month Change | 16.76% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 29.8M | ||
Total Assets | $18.6M | ||
Market Cap | $171.9M | ||
Enterprise Value | $166.6M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $14,451.00 | ||
Net Working Capital | N/A | ||
EPS | -$0.03 | ||
Enterprise Value/EBITDA | 11,528 | ||
Enterprise Value/Revenue | N/A | ||
P/B | N/A | ||
P/E | -192 | ||
PEG | -3 | ||
Price/Free Cash Flow | -105 | ||
Price/Operating Cash Flow | -105 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue